![]() |
市場調査レポート
商品コード
1439542
泌尿器科用レーザー - 世界市場の考察、競合情勢、市場予測(2030年)Urology Lasers - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
||||||
カスタマイズ可能
適宜更新あり
|
泌尿器科用レーザー - 世界市場の考察、競合情勢、市場予測(2030年) |
出版日: 2024年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の泌尿器科用レーザーの市場規模は、2023年に10億1,985万米ドル、2030年までに13億8,283万米ドルに達し、2024年~2030年の予測期間にCAGRで5.30%の成長が見込まれます。泌尿器科用レーザーの需要は、尿路結石、膀胱がん、前立腺疾患などの泌尿器科関連疾患の患者の増加や技術の進歩などによって促進されています。加えて、ホルミウムシステムやツリウムレーザー治療システムにおける低侵襲手術技法の採用、前述の疾患を患う老年人口の負担の増大、世界中でのデバイスの発売と承認の増加などが、2024年~2030年の予測期間における泌尿器科用レーザー市場の全体的な成長に寄与します。
泌尿器科用レーザーの市場力学
泌尿器科用レーザー市場は、さまざまな要因によって製品需要が伸びており、主な要因の1つは世界中での前立腺がん、膀胱がん、腎臓結石の有病率の増加です。
世界保健機関(WHO)(2020)によると、前立腺がんは男性で2番目に多く発生するがんであり、全体では4番目に多いがんです。2020年に世界中で140万人以上の前立腺がん患者が新たに発生しました。
WHOはまた、2040年までに約243万人の前立腺がんの新規症例が報告されると推定しています。
また、2020年に世界中で57万3,000件近くの膀胱がんの新規症例が報告され、この数は2040年までに世界中で99万1,000件に増加すると推定されています。
さらに、世界保健機関(2023)によれば、2021年~2022年に200万人以上が腎結石に罹患しており、世界の罹患率は毎年3~5%、生涯有病率は15~20%です。
したがって、前立腺がんや膀胱がん、腎結石などの泌尿器科疾患は、低侵襲治療アプローチである泌尿器科用レーザーを用いて治療することができます。また、これらのデバイスは、より高い効率性、安全性、迅速な回復などの利点があります。したがって、上記の疾患の有病率の増加が泌尿器科用レーザーの需要を高め、それによって予測期間の泌尿器科用レーザー市場が牽引されます。
さらに、レーザー手術には、治癒が早い、入院期間が短い、出血が少ない、切開創が小さいため全身の痛みが少ないなどの利点があります。その信頼性と安全性により、これらのシステムが市場拡大を促進すると予測されています。さらに、主要市場参入企業は定期的な製品の承認と開発に注力しており、予測期間を通じて市場を大きく牽引する見込みです。例えば、Olympusは2020年6月に新しいSoltive SuperPulsed Laser System(Soltive Laser System)を発表しました。この新しいツリウムファイバーレーザーアプリケーションは、軟部組織と結石破砕用途向けに開発されました。したがって、予測期間にこれらの変数が市場拡大を促進すると見込まれます。
しかし、デバイスや処置に関連する合併症や、レーザーシステムの高いコストなどが泌尿器科用レーザー市場の成長を抑制する可能性があります。
泌尿器科用レーザー市場のセグメント分析
泌尿器科用レーザー市場のレーザータイプセグメントでは、ホルミウムレーザーシステムカテゴリが2023年に大きな収益シェアを獲得すると予測されています。これは、その特殊なモダリティと低侵襲手術技法によるものと考えられます。
ホルミウムレーザーは主に前立腺手術に使用され、前立腺を通る尿の流れを阻害する組織の除去には低侵襲治療が好まれます。
ホルミウムシステムの需要は、切開手術を必要としない患者の治療におけるその安全性と有効性により増加しています。手術時間は前立腺の大きさにもよりますが、約45~90分です。侵襲が少ないため、患者はその日のうちに退院できます。
また、ホルミウムレーザー結石破砕術は成功率が高く、シュタインシュトラーセ(体外衝撃波結石破砕術の合併症で、結石の破片が尿管を閉塞する)の可能性も低いです。
当レポートでは、世界の泌尿器科用レーザー市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。
Urology Lasers Market By Laser Type (Holmium Laser System, Diode Laser Systems, Thulium Laser System, And Others), Application (Benign Prostatic Hyperplasia, Urolithiasis, Non-Muscle-Invasive Bladder Cancer, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of prostate cancer, kidney stones, bladder cancer, and other urological diseases and the rising demand for minimally invasive surgical procedures
The global urology lasers market was valued at USD 1,019.85 million in 2023, growing at a CAGR of 5.30% during the forecast period from 2024 to 2030 to reach USD 1,382.83 million by 2030. The demand for urology lasers is being boosted by the increase in the number of patients suffering from urology-related disorders such as urolithiasis, bladder cancer, urinary calculi, and prostate diseases and technological advancements, among others. In addition, the adoption of minimally invasive surgical techniques in holmium systems as well as thulium laser treatment systems, the rising burden of the geriatric population suffering from afore-said diseases, and the increasing device launches and approval across the globe among others are thereby contributing to the overall growth of the urology lasers market during the forecast period from 2024-2030.
Urology Lasers Market Dynamics:
The urology lasers market is witnessing a growth in product demand owing to various factors, one of the key factors being the increasing prevalence of prostate cancer, bladder cancer, and kidney stones across the globe.
According to World Health Organization (WHO) 2020, prostate cancer is the second most commonly occurring cancer in men and the fourth most common cancer overall. There were more than 1.4 million new cases of prostate cancer in 2020, across the globe.
The WHO also estimated that nearly 2.43 million new cases of prostate cancer will be reported in 2040.
The above-mentioned also stated that in 2020 nearly 573 thousand new cases of bladder cancer were reported across the globe and this number is estimated to increase to 991 thousand in 2040, globally.
Further, over two million people were affected by renal stone disease in 2021-2022 as per the World Health Organization (2023) with a global incidence of 3-5% annually and a lifetime prevalence of 15-20%.
Thus, urological disorders such as prostate and bladder cancer and kidney stones can be treated using urology laser, a minimally invasive treatment approach. These devices also offer several benefits, such as greater efficiency, safety, and rapid recovery. Therefore, the increasing prevalence of the above-mentioned diseases will increase the demand for urology lasers, thereby driving the market of urology lasers during the forecast period.
Additionally, laser operations have advantages like quicker healing, shorter hospital stays, less blood loss, and less generalized pain due to smaller incisions. Owing to their dependability and safety characteristics, these systems are anticipated to fuel market expansion. Additionally, major market participants are concentrating on regular product approvals and developments, which is anticipated to significantly drive the market throughout the forecast period. For instance, Olympus introduced its new Soltive SuperPulsed Laser System (Soltive Laser System) in June 2020. This new thulium fiber laser application was created for soft tissue and stone lithotripsy applications. Thus, during the anticipated period, these variables are projected to fuel market expansion.
However, complications related to device and procedure, the high cost of laser systems, and others may restrict the urology lasers market growth.
Urology Lasers Market Segment Analysis:
Urology Lasers market by Laser Type (Holmium Laser System, Diode Laser Systems, Thulium Laser System, and Others), Application (Benign Prostatic Hyperplasia, Urolithiasis, Non-Muscle-Invasive Bladder Cancer, and Others), and Geography (North America, Europe, Asia-Pacific, and the Rest of the World)
In the laser type segment of the urology lasers market, the holmium laser system category is expected to amass a significant revenue share in the year 2023. This can be attributed to its special modalities as well as its minimally invasive surgical technique.
Holmium laser is mainly used in prostate surgeries, for which a minimally invasive treatment is preferred for the removal of tissues that blocks urine flow through the prostate.
The demand for holmium systems is increasing due to their safety and effectiveness in the treatment of patients without an incision procedure. The procedure takes about 45-90 minutes depending on the size of the prostate. Since it is a less invasive procedure, the patients get can get discharged on the same day.
Also, holmium laser lithotripsy has higher success rates and decreased chance of steinstrasse (a complication of extracorporeal shockwave lithotripsy in which fragments of the stones block the ureter).
Further, the increasing product launches and approvals will also impact the market of holmium laser systems. For instance, in January 2021, Cook Medical launched Litho EVO holmium laser in the US, Austria, Germany, France, Ireland, Switzerland, and the UK. This laser is indicated for laparoscopic and endoscopic surgical techniques for lithotripsy and soft tissue procedures in urology, gastroenterology, and general surgery.
Thus, the above-mentioned factors are likely to propel the demand for holmium laser systems, thereby contributing to the growth of the urology lasers market during the forecast period from 2024-2030.
North America is expected to dominate the overall Urology Lasers Market:
Among all the regions, North America is estimated to account for the largest share of the Urology Lasers market in the year 2023. This domination is due to the rising prevalence of cancers of the urinary tract, growing preference for minimally invasive procedures due to less operative time and fewer complications, and rising geriatric population base, among others will propel the market of urology lasers in the United States.
According to the American Cancer Society, estimated that about 288,300 new cases of prostate cancer were will diagnosed in the United States in 2023. Also the same source, About 82,290 new cases of bladder cancer (about 62,420 in men and 19,870 in women). The increasing prevalence will also increase the demand for urology lasers as these lasers are used to destroy the tumor present in the body.
The product development activities and product approvals are further expected to drive the product demand in the region. For instance, in May 2022, OmniGuide Holdings (OGH), got the U.S. Food and Drug Administration clearance for RevoLix(TM) HTL a family of pulsed and continuous wave Thulium YAG lasers are the foundation of RevoLix Therapy for urology patients undergoing BPH and Stone Management procedures.
Thus, all the above-mentioned factors will lead to an increase in the North America urology lasers market growth during the forecasting period of 2024-2030.
Urology Lasers Market Key Players:
Some of the key market players operating in the Urology Lasers market include Boston Scientific Corporation, Richard Wolf GmbH., Allengers, B. Braun Melsungen AG, Cook Medical, biolitec® AG, El.En. S.p.A., Olympus, Advanced MedTech., OmniGuide Holdings, Inc., BD, Convergent Laser Technologies, EDAP TMS, Hyperphotonics, GIGAALASER, Asclepion Laser Technologies GmbH, KARL STORZ GmbH, INTERmedic Arfran, IPG Photonics Corporation, Fisioline, and others.
Recent Developmental Activities in the Urology Lasers Market:
In February 2023, Rhein Laser Technologies Ltd., a leading manufacturer of innovative medical lasers for urologic, aesthetic, and physiotherapy markets based in Wuhan and Dusseldorf, launched UroFiber(TM) 150Q which is the world's first 150W SuperPulsed thulium fiber laser (TFL) system, an innovative fiber laser technology for perfectly treating both stone lithotripsy and BPH enucleation.
In September 2021, Olympus launched a urology laser portfolio including iTind, the minimally invasive procedure for the treatment of enlarged prostate, and the SOLTIVE SuperPulsed Laser System for breaking up kidney and ureteral stones.
Key Takeaways from the Urology Lasers Market Report Study
Market size analysis for current urology lasers market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the urology lasers market.
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global urology lasers market.
Various opportunities available for the other competitor in the urology lasers market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current urology lasers market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for urology lasers market growth in the coming future?
Target Audience who can be benefited from this Urology Lasers Market Report Study
Urology lasers products providers
Research organizations and consulting companies
Urology Lasers-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in urology lasers
Various End-users who want to know more about the urology lasers market and the latest technological developments in the urology lasers market.
Frequently Asked Questions for the Urology Lasers Market:
Urological lasers are medical devices used to treat various urological diseases, including benign prostatic hyperplasia, urolithiasis, and non-muscle-invasive bladder cancer.
The global urology lasers market was valued at USD 1,019.85 million in 2023, growing at a CAGR of 5.30% during the forecast period from 2024 to 2030 to reach USD 1,382.83 million by 2030.
The demand for urology lasers is primarily being heightened by the growing geriatric population, increasing prevalence of chronic kidney diseases, increasing figures of prostate cancer, kidney stones, bladder cancer, and other urological diseases, and increasing device launches and approvals, among others, thereby contribute to the overall growth of the urology lasers market during the forecast period from 2024-2030.
Some of the key market players operating in the urology lasers market include Boston Scientific Corporation, Richard Wolf GmbH., Allengers, B. Braun Melsungen AG, Cook Medical, biolitec® AG, El.En. S.p.A., Olympus, Advanced MedTech., OmniGuide Holdings, Inc., BD, Convergent Laser Technologies, EDAP TMS, Hyperphotonics, GIGAALASER, Asclepion Laser Technologies GmbH, KARL STORZ GmbH, INTERmedic Arfran, IPG Photonics Corporation, Fisioline, and others.
North America is expected to dominate the overall urology lasers market during the forecast period from 2024-2030. Factors such as the increasing prevalence of urological disorders, such as bladder cancer and urinary incontinence, the growing preference for minimally invasive procedures due to less operative time and fewer complications, and the presence of key players in the region, among others will positively impact the North America urology lasers market. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new drugs, and high awareness about the advantages offered by lasers over other treatment options also helped the market growth in this region.